EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Clinical trial NCT02705313 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02705313
- Sponsor
- Advanced Accelerator Applications
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.